This session will focus on the role of anti-fibrinolytics and other hemostatic agents/adjuncts (such as prothrombin concentrates, rFVIIa, fibrinogen concentrates/cryoprecipitate) in controlling bleeding and lowering transfusion needs in pediatric trauma situations. Key animal experimental studies and pediatric/adult clinical studies that support its use in attenuating bleeding in pediatric patients will be presented. In addition, assays that can guide the use of hemostatic agents/adjuncts will be described.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM23-ST-18-O: Potential Role of Intravenous Hemostatic Agents/Adjuncts in Pediatric Trauma: A Review of the Evidence for (or Against) Their Use (Enduring) Evaluation